Unicycive Therapeutics Inc (UNCY)

Feb 24, 2025

Unicycive Therapeutics Inc (NASDAQ: UNCY) Is One Of The Hottest Stocks Right Now. - Stocks Register

Feb 24, 2025

Feb 20, 2025

Unicycive reports potential kidney disease treatment advance By Investing.com - Investing.com Nigeria

Feb 20, 2025

Feb 20, 2025

Unicycive Therapeutics Announces the Publication of Preclinical Data on Synergies Between Oxylanthanum Carbonate and Tenapanor in American Society of Nephrology Journal Kidney360 - The Manila Times

Feb 20, 2025

Feb 20, 2025

Unicycive reports potential kidney disease treatment advance - Investing.com

Feb 20, 2025

Feb 20, 2025

Unicycive Therapeutics Announces the Publication of - GlobeNewswire

Feb 20, 2025

Feb 20, 2025

Groundbreaking Kidney Disease Treatment Shows 41% Better ResultsCan This Change Dialysis Patient Care? - StockTitan

Feb 20, 2025

Feb 14, 2025

Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Short Interest Down 51.6% in January - MarketBeat

Feb 14, 2025

Feb 10, 2025

Trading Day Review: Unicycive Therapeutics Inc (UNCY) Loses Momentum, Closing at 0.57 - The Dwinnex

Feb 10, 2025

Feb 10, 2025

Investing in Unicycive Therapeutics Inc [UNCY]: What You Must Know - Knox Daily

Feb 10, 2025

Feb 05, 2025

Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Is Expected To Breakeven In The Near Future - Simply Wall St

Feb 05, 2025

Feb 04, 2025

Should investors be concerned about Unicycive Therapeutics Inc (UNCY)? - US Post News

Feb 04, 2025

Feb 04, 2025

Short Interest in Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Rises By 25.4% - MarketBeat

Feb 04, 2025

Feb 03, 2025

Trading Day Review: Unicycive Therapeutics Inc (UNCY) Gains Momentum, Closing at 0.61 - The Dwinnex

Feb 03, 2025

Feb 02, 2025

Unicycive Therapeutics' (UNCY) Buy Rating Reiterated at HC Wainwright - MarketBeat

Feb 02, 2025

Feb 01, 2025

Unicycive highlights challenges in phosphate management - MSN

Feb 01, 2025

Jan 31, 2025

Unicycive Therapeutics Inc (UNCY) Has A Gold Mine On Its Hands - Stocks Register

Jan 31, 2025

Jan 31, 2025

Unicycive Therapeutics (NASDAQ:UNCY) Earns “Buy” Rating from HC Wainwright - Defense World

Jan 31, 2025

Jan 28, 2025

Unicycive Therapeutics Announces the Publication of Patient - GlobeNewswire

Jan 28, 2025

Jan 28, 2025

Unicycive highlights challenges in phosphate management By Investing.com - Investing.com Australia

Jan 28, 2025

Jan 28, 2025

Unicycive Therapeutics Publishes Review on Patient Perspectives in Phosphate Management for Chronic Kidney Disease - Nasdaq

Jan 28, 2025

Jan 28, 2025

Unicycive Therapeutics Announces the Publication of Patient Perspectives on Phosphate Management in the Journal of Nephrological Science - GlobeNewswire Inc.

Jan 28, 2025

Jan 28, 2025

Here's Why We're Watching Unicycive Therapeutics' (NASDAQ:UNCY) Cash Burn Situation - Yahoo Finance

Jan 28, 2025

Jan 26, 2025

Analyzing Imunon (NASDAQ:IMNN) & Unicycive Therapeutics (NASDAQ:UNCY) - Defense World

Jan 26, 2025

Jan 16, 2025

Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Short Interest Update - MarketBeat

Jan 16, 2025

Jan 11, 2025

Unicycive Therapeutics’ (UNCY) Buy Rating Reiterated at HC Wainwright - Defense World

Jan 11, 2025

Jan 10, 2025

Unicycive Therapeutics Receives Notice of Non-Compliance from Nasdaq - Defense World

Jan 10, 2025

Jan 08, 2025

Unicycive Therapeutics (NASDAQ:UNCY) Receives "Buy" Rating from HC Wainwright - MarketBeat

Jan 08, 2025

Jan 07, 2025

Unicycive Therapeutics granted extension to meet Nasdaq compliance - Investing.com

Jan 07, 2025

Jan 07, 2025

Unicycive Therapeutics granted extension to meet Nasdaq compliance By Investing.com - Investing.com Canada

Jan 07, 2025

Jan 07, 2025

Unicycive reports positive phase 1 results for kidney drug By Investing.com - Investing.com Australia

Jan 07, 2025

Jan 07, 2025

Unicycive reports positive phase 1 results for kidney drug - Investing.com

Jan 07, 2025

Jan 07, 2025

Unicycive Therapeutics Announces Publication of Positive - GlobeNewswire

Jan 07, 2025

Jan 07, 2025

Unicycive's OLC Drug Shows Strong Safety Profile in Phase 1 Trial, FDA Decision Due 2025 - StockTitan

Jan 07, 2025

Jan 02, 2025

Unicycive Therapeutics Inc (NASDAQ: UNCY) Is A Safe Investment Now, Isn’t It? - Stocks Register

Jan 02, 2025

Dec 17, 2024

Unicycive Therapeutics Announces Publication of Oxylanthanum Carbonate (OLC) Positive Bioequivalence Data in Clinical Therapeutics - The Manila Times

Dec 17, 2024

Dec 17, 2024

Unicycive Therapeutics Announces Publication of - GlobeNewswire

Dec 17, 2024

Dec 17, 2024

Unicycive Therapeutics (NASDAQ:UNCY) and Arvinas (NASDAQ:ARVN) Head-To-Head Review - Defense World

Dec 17, 2024

Dec 14, 2024

Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Sees Significant Decline in Short Interest - MarketBeat

Dec 14, 2024

Dec 13, 2024

Unicycive Therapeutics Inc (NASDAQ: UNCY): Overvalued In Comparison To Others? - Stocks Register

Dec 13, 2024

Dec 12, 2024

Analyzing Unicycive Therapeutics (NASDAQ:UNCY) and FibroGen (NASDAQ:FGEN) - Defense World

Dec 12, 2024

Dec 11, 2024

We're Hopeful That Unicycive Therapeutics (NASDAQ:UNCY) Will Use Its Cash Wisely - Simply Wall St

Dec 11, 2024

Dec 04, 2024

5,000,000 Shares in Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Purchased by Walleye Capital LLC - MarketBeat

Dec 04, 2024

Nov 28, 2024

Acuta Capital Partners LLC Takes $807,000 Position in Unicycive Therapeutics, Inc. (NASDAQ:UNCY) - MarketBeat

Nov 28, 2024

Nov 28, 2024

Breakeven On The Horizon For Unicycive Therapeutics, Inc. (NASDAQ:UNCY) - Yahoo Finance

Nov 28, 2024

Nov 27, 2024

Great Point Partners LLC Takes $3.49 Million Position in Unicycive Therapeutics, Inc. (NASDAQ:UNCY) - MarketBeat

Nov 27, 2024

Nov 25, 2024

Unicycive's SWOT analysis: CKD treatment innovator's stock faces pivotal year - Investing.com India

Nov 25, 2024

Nov 24, 2024

Unicycive Therapeutics (UNCY) Price Target Increased by 14.13% to 4.46 - MSN

Nov 24, 2024

Nov 23, 2024

Unicycive Therapeutics (NASDAQ:UNCY) Receives "Speculative Buy" Rating from Benchmark - MarketBeat

Nov 23, 2024